NASDAQ: AMGN
Amgen Inc Stock Ownership - Who owns Amgen?

Insider buying vs selling

Have Amgen Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Murdo GordonEVP Global Commercial Ops2026-05-07615$331.11
$203.63kSell
Jonathan P. GrahamEVP Gen. Counsel Sec.2026-05-07499$331.11
$165.22kSell
Robert A. BradwayChairman CEO and President2026-05-072,079$331.11
$688.38kSell
Peter H. GriffithEVP CFO2026-05-07556$331.11
$184.10kSell
Esteban SantosEVP Operations2026-05-07522$331.11
$172.84kSell
David M. ReeseEVP Chief Technology Officer2026-05-07556$331.11
$184.10kSell
James E. BradnerEVP Research and Development2026-05-07446$331.11
$147.68kSell
Derek MillerSVP Human Resources2026-05-07151$331.11
$50.00kSell
Matthew C. BuschVP Finance CAO2026-05-0741$331.11
$13.58kSell
Nancy A. GrygielSVP CCO2026-05-0788$331.11
$29.14kSell

1 of 8

AMGN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AMGN insiders and whales buy or sell their stock.

AMGN Shareholders

What type of owners hold Amgen Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc10.16%54,838,826$18.07BInstitution
Blackrock Inc8.78%47,396,138$15.62BInstitution
State Street Corp5.67%30,591,403$10.08BInstitution
Capital World Investors4.28%23,097,711$7.61BInstitution
Capital International Investors3.37%18,186,270$5.99BInstitution
Morgan Stanley2.92%15,744,528$5.19BInstitution
Geode Capital Management LLC2.65%14,303,294$4.71BInstitution
Charles Schwab Investment Management Inc2.19%11,811,045$3.89BInstitution
Primecap Management Co1.65%8,904,979$2.93BInstitution
Wells Fargo Company1.32%7,110,693$2.34BInstitution

1 of 3

AMGN vs General Drug Manufacturer Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AMGN80.88%1.01%Net SellingNet Selling
GILD87.88%1.12%Net SellingNet Selling
PFE65.46%0.27%Net SellingNet Buying
BMY80.27%0.37%Net SellingNet Selling
SNY18.35%0.00%

Amgen Stock Ownership FAQ

Who owns Amgen?

Amgen (NASDAQ: AMGN) is owned by 80.88% institutional shareholders, 1.01% Amgen insiders, and 18.11% retail investors. Vanguard Group Inc is the largest individual Amgen shareholder, owning 54.84M shares representing 10.16% of the company. Vanguard Group Inc's Amgen shares are currently valued at $18.44B.

If you're new to stock investing, here's how to buy Amgen stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.